We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Cheap option

17 August 2011 By Robert Cyran

Based on the yawning 26 pct gap between the Express Scripts offer and where Medco shares trade – lower than even before the bid came along – investors are super-spooked about antitrust issues. The market pricing in zero chance of success makes it a cheap option to buy.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)